Eramox 400 mg/250 ml (IV Infusion)
250 ml bottle: ৳ 350.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Moxifloxacin hydrochloride injection |
| Company | Beacon pharmaceuticals plc |
Indications
- Acute Bacterial Sinusitis
- Acute Bacterial Exacerbation of Chronic Bronchitis
- Community Acquired Pneumonia
- Skin and Skin Structure Infections: Uncomplicated and Complicated
- Complicated Intra-Abdominal Infections
Dosage
- 400 mg once daily for Acute Bacterial Sinusitis
- 400 mg once daily for Acute Bacterial Exacerbation of Chronic Bronchitis
- 400 mg once daily for Community Acquired Pneumonia
- 400 mg once daily for Uncomplicated Skin and Skin Structure Infections
- 400 mg once daily for Complicated Skin and Skin Structure Infections
- 400 mg once daily for Complicated Intra-Abdominal Infections
Administration
- Intravenous infusion over a period of 60 minutes
- Check the bag for minute leaks by squeezing the inner bag firmly
- Do not use if the solution is cloudy or a precipitate is present
- Avoid bolus or rapid infusion
- Regulate the rate of administration with flow control clamp
- Suspend bag from hanger
Interaction
- Avoid co-administration with any solution containing multivalent cations
- Enhanced anticoagulant effects of warfarin or its derivatives
- Potential for CNS stimulation and convulsions when combined with a nonsteroidal anti-inflammatory drug
- Avoid with Class IA and Class III antiarrhythmics
Contraindications
- Known hypersensitivity to Moxifloxacin or other quinolone antibacterials
Side Effects
- Headache
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Dizziness
- Pyrexia
- Insomnia
- Neutropenia
- Palpitations
- Tachycardia
- Bradycardia
Pregnancy & Lactation
- Pregnancy Category C
- Excretion in breast milk
- Potential for serious adverse reactions in nursing infants
Precautions & Warnings
- Increased risk of tendinitis and tendon rupture
- Exacerbation of muscle weakness in persons with myasthenia gravis
- Clostridium difficile-associated diarrhea (CDAD)
Use in Special Populations
- Safety and effectiveness not established in pediatric patients and adolescents
- Increased risk for severe tendon disorders in geriatric patients
Therapeutic Class
- 4-Quinolone preparations
Storage Conditions
- Store below 25°C and protect from light
- Avoid extreme heat and freezing
- Keep out of reach of children